3.5.4. Gene silencing using siRNA and antisense oligonucleotides

Gene silencing is a method used to inhibit gene expression. It employs different techniques, with siRNA (small interfering RNA) and antisense oligonucleotides being two of the most notable.

Gene silencing refers to a range of techniques to reduce or eliminate the expression of specific genes. The goal is to prevent those genes from producing their corresponding proteins, which can be beneficial for treating diseases caused by the overexpression of harmful genes. The two primary methods for achieving gene silencing are siRNA and antisense oligonucleotides, each employing different biological mechanisms to inhibit gene function.

Think of a gene as a recipe in a cookbook, with its expression being cooking that dish. Gene silencing is like removing certain recipes from the cookbook so they cannot be followed anymore. Both siRNA and antisense oligonucleotides act as tools to 'erase' or 'block' these recipes, preventing the cooking (or production of proteins) from happening.

siRNA works by binding to complementary mRNA molecules, leading to their degradation and consequently silencing the expression of the target gene.

Small interfering RNA (siRNA) are short strands of RNA that play a crucial role in the RNA interference pathway. When introduced into a cell, siRNA will find and bind to messenger RNA (mRNA) that is complementary in sequence to it. This binding triggers a cellular process that results in the degradation of that mRNA. As the mRNA is destroyed, the gene that it originally encoded for is no longer expressed, leading to reduced production of the corresponding protein.

Consider siRNA as a pair of scissors that find a specific paper in a stack. The paper represents the mRNA, and the scissors can cut it up into pieces so it can no longer be read, much like how siRNA cuts the mRNA and prevents the gene expression associated with it.

Antisense oligonucleotides are short, single-stranded pieces of DNA or RNA that bind to target mRNA, blocking its translation into protein.

Antisense oligonucleotides (ASOs) are synthetic strands that are designed to be complementary to a specific mRNA sequence. When administered, they bind to the target mRNA and interfere with its translation process. This prevents the ribosome, the cellular machinery that assembles proteins, from reading the mRNA and translating it into a protein, effectively silencing the gene. ASOs can also recruit enzymes that degrade mRNA, further enhancing their silencing effect.

Imagine ASOs as a ‘jammer’ in a radio system. If the radio is trying to tune into a specific station (the mRNA), the jammer will block that signal, preventing the radio from playing music (the protein being produced). This blockage of the signal interrupts the gene expression process.

Gene silencing is a powerful tool in research and therapeutic applications, particularly in targeting diseases like cancers and genetic disorders.

Gene silencing has vast applications in both research and clinical settings. In research, scientists use siRNA and antisense oligonucleotides to study gene function by turning off specific genes and observing the effects. In clinical settings, these methods show promise for treating various diseases, particularly cancers where certain genes promote tumor growth or genetic disorders where faulty genes cause disease symptoms. By silencing these harmful genes, it may be possible to alleviate symptoms or even cure the disease.

Think of gene silencing like using a light switch in a room. By flipping the switch off (silencing the gene), you stop the 'light' (protein) from illuminating the room (affecting the body). In treating diseases, flipping the switch off for harmful genes can help 'darken' or 'remove' the effects of those diseases.

--